Immunogenicity of HLA-A1-restricted peptides derived from S100A4 (metastasin 1) in melanoma patients

Cancer Immunology, Immunotherapy

Volumn 58, Issue 8, 2009, Pages 1265-1273

  Hofmeister Mueller, Valeska ^a   Vetter Kauczok, Claudia S ^a   Ullrich, Ramona ^a   Meder, Katharina ^a   Lukanidin, Eugene ^b   Broecker, Eva Bettina ^a   Thor Straten, Per ^c   Andersen, Mads Hald ^c   Schrama, David ^a   Becker, Juergen C ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

CTL; HLA A1 epitope; Melanoma; Metastasin 1; S100A4; Tumor stroma

Indexed keywords

CALCIUM BINDING PROTEIN; CALVASCULIN; HLA A1 ANTIGEN; HLA A2 ANTIGEN; HLA A3 ANTIGEN;

ARTICLE; CANCER IMMUNOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; DRUG PROTEIN BINDING; ENZYME LINKED IMMUNOSPOT ASSAY; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; MACROPHAGE ACTIVATION; MELANOMA; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN PROCESSING;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; CELLS, CULTURED; EPITOPES; HLA-A1 ANTIGEN; HUMANS; INTERFERON-GAMMA; MELANOMA; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; S100 PROTEINS; SEQUENCE ALIGNMENT; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 67349108019     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-008-0640-0     Document Type: Article

References (57)

1. M Agerbaek J Alsner N Marcussen F Lundbeck MH Von der 2006 Focal S100A4 protein expression is an independent predictor of development of metastatic disease in cystectomized bladder cancer patients Eur Urol 50 777 785 (Pubitemid 44332664)
2. KX Ai LY Lu XY Huang W Chen HZ Zhang 2008 Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer World J Gastroenterol 14 1931 1935
3. K Andersen JM Nesland R Holm VA Florenes O Fodstad GM Maelandsmo 2004 Expression of S100A4 combined with reduced E-cadherin expression predicts patient outcome in malignant melanoma Mod Pathol 17 990 997 (Pubitemid 38993784)
4. DP Basile K Fredrich M Alausa CP Vio M Liang MR Rieder AS Greene AW Cowley Jr 2005 Identification of persistently altered gene expression in the kidney after functional recovery from ischemic acute renal failure Am J Physiol Renal Physiol 288 F953 F963
5. Z Berke MH Andersen M Pedersen L Fugger J Zeuthen JS Haurum 2000 Peptides spanning the junctional region of both the abl/bcr and the bcr/abl fusion proteins bind common HLA class I molecules Leukemia 14 419 426 (Pubitemid 30142865)
6. AC Brisset H Hao E Camenzind M Bacchetta A Geinoz JC Sanchez C Chaponnier G Gabbiani ML Bochaton-Piallat 2007 Intimal smooth muscle cells of porcine and human coronary artery express S100A4, a marker of the rhomboid phenotype in vitro Circ Res 100 1055 1062 (Pubitemid 46598930)
7. EB Brocker KM Kuhlencordt W Muller-Ruchholtz 1977 Microcytotoxicity test in allograft immunity: specificity and kinetics of effector T cells Int Arch Allergy Appl Immunol 53 234 241 (Pubitemid 8069472)
8. T Cabezon JE Celis I Skibshoj J Klingelhofer M Grigorian P Gromov F Rank JH Myklebust GM Maelandsmo E Lukanidin N Ambartsumian 2007 Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer Int J Cancer 121 1433 1444 (Pubitemid 47328701)
9. HJ Chang BC Yoo SW Kim BL Lee WH Kim 2007 Significance of PML and p53 protein as molecular prognostic markers of gallbladder carcinomas Pathol Oncol Res 13 326 335
10. YG Cho CJ Kim SW Nam SH Yoon SH Lee NJ Yoo JY Lee WS Park 2005 Overexpression of S100A4 is closely associated with progression of colorectal cancer World J Gastroenterol 11 4852 4856
11. BR Davies M O'Donnell GC Durkan PS Rudland R Barraclough DE Neal JK Mellon 2002 Expression of S100A4 protein is associated with metastasis and reduced survival in human bladder cancer J Pathol 196 292 299 (Pubitemid 34189418)
12. RS de Silva L Martin C Roshanlall J Winstanley S Leinster A Platt-Higgins J Carroll C West R Barraclough P Rudland 2006 Association of S100A4 and osteopontin with specific prognostic factors and survival of patients with minimally invasive breast cancer Clin Cancer Res 12 1192 1200 (Pubitemid 43342508)
13. M DiBrino T Tsuchida RV Turner KC Parker JE Coligan WE Biddison 1993 HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs J Immunol 151 5930 5935 (Pubitemid 23340338)
14. K Ganesan T Ivanova Y Wu V Rajasegaran J Wu MH Lee K Yu SY Rha HC Chung B Ylstra G Meijer KO Lian H Grabsch P Tan 2008 Inhibition of gastric cancer invasion and metastasis by PLA2G2A, a novel beta-catenin/TCF target gene Cancer Res 68 4277 4286
15. SC Garrett KM Varney DJ Weber AR Bresnick 2006 S100A4, a mediator of metastasis J Biol Chem 281 677 680
16. M Grigorian E Tulchinsky O Burrone S Tarabykina G Georgiev E Lukanidin 1994 Modulation of mts1 expression in mouse and human normal and tumor cells Electrophoresis 15 463 468 (Pubitemid 24151845)
17. S Gupta T Hussain GT MacLennan P Fu J Patel H Mukhtar 2003 Differential expression of S100A2 and S100A4 during progression of human prostate adenocarcinoma J Clin Oncol 21 106 112
18. DM Helfman EJ Kim E Lukanidin M Grigorian 2005 The metastasis associated protein S100A4: role in tumour progression and metastasis Br J Cancer 92 1955 1958 (Pubitemid 40897415)
19. AK Hemandas M Salto-Tellez SH Maricar AF Leong CK Leow 2006 Metastasis-associated protein S100A4-a potential prognostic marker for colorectal cancer J Surg Oncol 93 498 503 (Pubitemid 44651274)
20. V Hofmeister D Schrama JC Becker 2008 Anti-cancer therapies targeting the tumor stroma Cancer Immunol Immunother 57 1 17 (Pubitemid 350043655)
21. V Hofmeister C Vetter D Schrama EB Brocker JC Becker 2006 Tumor stroma-associated antigens for anti-cancer immunotherapy Cancer Immunol Immunother 55 481 494
22. NI Ismail G Kaur H Hashim MS Hassan 2008 S100A4 overexpression proves to be independent marker for breast cancer progression Cancer Cell Int 8 12 10.1186/1475-2867-8-12
23. Y Ito H Yoshida C Tomoda T Uruno A Miya K Kobayashi F Matsuzuka K Kakudo K Kuma A Miyauchi 2004 S100A4 expression is an early event of papillary carcinoma of the thyroid Oncology 67 397 402
24. L Ji WG Zhang J Liu XP Liu LB Yao 2004 Construction and analysis of subtractive cDNA library associated with multidrug resistance of acute leukemia Zhongguo Shi Yan Xue Ye Xue Za Zhi 12 431 435
25. N Kikuchi A Horiuchi R Osada T Imai C Wang X Chen I Konishi 2006 Nuclear expression of S100A4 is associated with aggressive behavior of epithelial ovarian carcinoma: an important autocrine/paracrine factor in tumor progression Cancer Sci 97 1061 1069 (Pubitemid 44322555)
26. YJ Kim MA Kim SA Im TM Kim DW Kim HK Yang DS Heo KU Lee KJ Choe NK Kim TY Kim WH Kim YJ Bang 2008 Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer Cancer Invest 26 152 158
27. K Kimura Y Endo Y Yonemura CW Heizmann BW Schafer Y Watanabe T Sasaki 2000 Clinical significance of S100A4 and E-cadherin-related adhesion molecules in non-small cell lung cancer Int J Oncol 16 1125 1131
28. EN Kozlova E Lukanidin 1999 Metastasis-associated mts1 (S100A4) protein is selectively expressed in white matter astrocytes and is up-regulated after peripheral nerve or dorsal root injury Glia 27 249 258 (Pubitemid 29413915)
29. EN Kozlova E Lukanidin 2002 Mts1 protein expression in the central nervous system after injury Glia 37 337 348
30. WY Lee WC Su PW Lin HR Guo TW Chang HH Chen 2004 Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer Oncology 66 429 438 (Pubitemid 39370233)
31. H Li X Fan J Houghton 2007 Tumor microenvironment: the role of the tumor stroma in cancer J Cell Biochem 101 805 815 (Pubitemid 47040863)
32. GM Maelandsmo VA Florenes T Mellingsaeter E Hovig RS Kerbel O Fodstad 1997 Differential expression patterns of S100A2, S100A4 and S100A6 during progression of human malignant melanoma Int J Cancer 74 464 469 (Pubitemid 27400171)
33. GM Maelandsmo E Hovig M Skrede O Engebraaten VA Florenes O Myklebost M Grigorian E Lukanidin KJ Scanlon O Fodstad 1996 Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts1) ribozyme Cancer Res 56 5490 5498 (Pubitemid 27011385)
34. D Matsubara T Niki S Ishikawa A Goto E Ohara T Yokomizo CW Heizmann H Aburatani S Moriyama H Moriyama Y Nishimura N Funata M Fukayama 2005 Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes Cancer Sci 96 844 857 (Pubitemid 43056122)
35. Middleton D, Menchaca L, Rood H, Komerofsky R (2003) New allele frequency database: http://www.allelefrequencies.net. Tissue Antigens 61:403-407
36. HS Min G Choe SW Kim YJ Park DJ Park YK Youn SH Park BY Cho SY Park 2008 S100A4 expression is associated with lymph node metastasis in papillary microcarcinoma of the thyroid Mod Pathol 21 748 755
37. LL Nikitenko BH Lloyd PS Rudland S Fear R Barraclough 2000 Localisation by in situ hybridisation of S100A4 (p9Ka) mRNA in primary human breast tumour specimens Int J Cancer 86 219 228 (Pubitemid 30180817)
38. I Ninomiya T Ohta S Fushida Y Endo T Hashimoto M Yagi T Fujimura G Nishimura T Tani K Shimizu Y Yonemura CW Heizmann BW Schafer T Sasaki K Miwa 2001 Increased expression of S100A4 and its prognostic significance in esophageal squamous cell carcinoma Int J Oncol 18 715 720
39. D Nonaka L Chiriboga BP Rubin 2008 Differential expression of S100 protein subtypes in malignant melanoma, and benign and malignant peripheral nerve sheath tumors J Cutan Pathol 35 1014 1019
40. Y Oida H Yamazaki K Tobita M Mukai Y Ohtani N Miyazaki Y Abe T Imaizumi H Makuuchi Y Ueyama M Nakamura 2006 Increased S100A4 expression combined with decreased E-cadherin expression predicts a poor outcome of patients with pancreatic cancer Oncol Rep 16 457 463
41. L Oslejskova M Grigorian S Gay M Neidhart L Senolt 2008 The metastasis associated protein S100A4: a potential novel link to inflammation and consequent aggressive behavior of rheumatoid arthritis synovial fibroblasts Ann Rheum Dis 67 1499 1504
42. KC Parker MA Bednarek JE Coligan 1994 Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains J Immunol 152 163 175
43. H Rammensee J Bachmann NP Emmerich OA Bachor S Stevanovic 1999 SYFPEITHI: database for MHC ligands and peptide motifs Immunogenetics 50 213 219 (Pubitemid 30099526)
44. V Rand E Prebble L Ridley M Howard W Wei MA Brundler BE Fee GJ Riggins B Coyle RG Grundy 2008 Investigation of chromosome 1q reveals differential expression of members of the S100 family in clinical subgroups of intracranial paediatric ependymoma Br J Cancer 99 1136 1143
45. C Rosty T Ueki P Argani M Jansen CJ Yeo JL Cameron RH Hruban M Goggins 2002 Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation Am J Pathol 160 45 50 (Pubitemid 34052264)
46. PS Rudland A Platt-Higgins C Renshaw CR West JH Winstanley L Robertson R Barraclough 2000 Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer Cancer Res 60 1595 1603 (Pubitemid 30183430)
47. L Santamaria-Kisiel AC Rintala-Dempsey GS Shaw 2006 Calcium-dependent and -independent interactions of the S100 protein family Biochem J 396 201 214 (Pubitemid 43837235)
48. B Schmidt-Hansen J Klingelhofer B Grum-Schwensen A Christensen S Andresen C Kruse T Hansen N Ambartsumian E Lukanidin M Grigorian 2004 Functional significance of metastasis-inducing S100A4 (Mts1) in tumor-stroma interplay J Biol Chem 279 24498 24504 (Pubitemid 38725315)
49. M Schneider JL Hansen SP Sheikh 2008 S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases? J Mol Med 86 507 522
50. M Schneider S Kostin CC Strom M Aplin S Lyngbaek J Theilade M Grigorian CB Andersen E Lukanidin HJ Lerche SP Sheikh 2007 S100A4 is upregulated in injured myocardium and promotes growth and survival of cardiac myocytes Cardiovasc Res 75 40 50 (Pubitemid 46881062)
51. Y Shi M Zou K Collison EY Baitei Z Al Makhalafi NR Farid FA Al Mohanna 2006 Ribonucleic acid interference targeting S100A4 (Mts1) suppresses tumor growth and metastasis of anaplastic thyroid carcinoma in a mouse model J Clin Endocrinol Metab 91 2373 2379 (Pubitemid 43855030)
52. K Takenaga J Nygren M Zelenina M Ohira T Iuchi E Lukanidin M Sjoquist EN Kozlova 2007 Modified expression of Mts1/S100A4 protein in C6 glioma cells or surrounding astrocytes affects migration of tumor cells in vitro and in vivo Neurobiol Dis 25 455 463 (Pubitemid 46304235)
53. S Taylor S Herrington W Prime PS Rudland R Barraclough 2002 S100A4 (p9Ka) protein in colon carcinoma and liver metastases: association with carcinoma cells and T-lymphocytes Br J Cancer 86 409 416 (Pubitemid 34185126)
54. G Wang A Platt-Higgins J Carroll RS de Silva J Winstanley R Barraclough PS Rudland 2006 Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients Cancer Res 66 1199 1207 (Pubitemid 43165991)
55. Y Yonemura Y Endou K Kimura S Fushida E Bandou K Taniguchi K Kinoshita I Ninomiya K Sugiyama CW Heizmann BW Schafer T Sasaki 2000 Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer Clin Cancer Res 6 4234 4242
56. B Zhang NA Bowerman JK Salama H Schmidt MT Spiotto A Schietinger P Yu YX Fu RR Weichselbaum DA Rowley DM Kranz H Schreiber 2007 Induced sensitization of tumor stroma leads to eradication of established cancer by T cells J Exp Med 204 49 55 (Pubitemid 46148755)
57. M Zou RS Al Baradie H Al Hindi NR Farid Y Shi 2005 S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma Br J Cancer 93 1277 1284 (Pubitemid 41679414)